Rockley Photonics Holdings Limited (NYSE: RKLY) (“Rockley”), a
global leader in photonics-based health monitoring and
communications solutions, today announced that it has joined the
Center to Stream Healthcare in Place (C2SHIP).
Funded by the U.S. National Science Foundation (NSF), C2SHIP is
a consortium of leading academic centers and industry partners with
a mission to develop technologies and approaches for high-quality
personalized healthcare delivered at home. Current participating
academic centers in C2SHIP include the University of Arizona,
Baylor College of Medicine, University of Southern California, the
California Institute of Technology, and the University of
Missouri.
In this collaboration, Rockley will target new applications for
its multi-biomarker wearable sensing technologies. Rockley expects
that its products will help satisfy the increasing demand to bring
non-invasive remote monitoring solutions outside the clinic or
hospital and to the home.
“One of the key goals of C2SHIP is accelerating the application
of cutting-edge technologies to in-place patient care, while
introducing students and fellows to new methods for improving
remote patient care,” said Bijan Najafi, Ph.D., professor of
surgery, director of clinical research at the division of vascular
surgery, and director of C2SHIP at the Baylor College of Medicine.
“We are pleased to welcome Rockley Photonics to C2SHIP as one of
our industrial members. Rockley brings its exciting infrared
spectrophotometer-on-a-chip technology to the Center, along with
its cloud-enabled AI capabilities. Rockley’s approach and expertise
are well aligned with the mission of C2SHIP, and we expect that its
participation will help accelerate our efforts to take in-place
remote monitoring to new heights.”
“We are truly pleased to join C2SHIP. The expansion of in-home
care capabilities is a growing and vitally important priority
across the board, for consumers, patients, loved ones, caregivers,
and healthcare providers,” said Andrew Rickman, founder and chief
executive officer of Rockley. “C2SHIP is a forward-looking
collaborative initiative that offers an exciting opportunity for us
to join forces with leading researchers and academics in
healthcare. Our technology has the potential to create a new class
of wearable monitoring capabilities, and we look forward to helping
C2SHIP enhance the ability to provide new digital health insights
and peace of mind to everyone involved.”
About C2SHIP
The mission of the Center to Stream Healthcare in Place (C2SHIP)
is to engage academic and industrial partners in joint efforts that
develop healthcare technologies for in-place care and accelerate
innovation through multi-specialty collaborations. The Center's
strategy is to emphasize fundamental investigations that provide an
in-depth understanding of the core disciplines needed for
personalized technology that promotes in-place care, to establish
effective interactions with Center members to promote innovation
capacity and accelerate technology transfer, and to promote
collaborations with other existing centers to create multi-center
innovative technology for the involved core disciplines. C2SHIP is
part of the U.S. National Science Foundation (NSF)
Industry/University Cooperative Research Centers (I/UCRC) program.
For more information visit C2SHIP.org.
About Rockley Photonics
A global leader in photonics-based health monitoring and
communications solutions, Rockley Photonics is developing a
comprehensive range of photonic integrated circuits and associated
modules, sensors, and full-stack solutions. From next-generation
sensing platforms specifically designed for mobile health
monitoring and machine vision to high-speed, high-volume solutions
for data communications, Rockley is laying the foundation for a new
generation of applications across multiple industries. Rockley
believes that photonics will eventually become as pervasive as
micro-electronics, and it has developed a platform with the power
and flexibility needed to address both mass markets and a wide
variety of vertical applications.
Formed in 2013, Rockley is uniquely positioned to support
hyper-scale manufacturing and address a multitude of high-volume
markets. Rockley has partnered with numerous tier-1 customers
across a diverse range of industries to deliver the complex optical
systems required to bring transformational products to market.
To learn more about Rockley, visit rockleyphotonics.com.
Cautionary Note Regarding Forward-Looking Statements
Statements in this press release that are not historical facts
constitute “forward-looking statements” for purposes of the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements include statements
regarding Rockley’s future expectations, beliefs, plans,
objectives, and assumptions regarding future events or performance.
The words “accelerate,” “advance,” “allow,” “anticipate,”
“believe,” “can,” “capability,” “continue,” “could,” “develop,”
“enable,” “estimate,” “eventual,” “expand,” “expect,” “focus,”
“forward,” “future,” “goal,” “intend,” “may,” “might,”
“opportunity,” “outlook,” “plan,” “possible,” “position,”
“potential,” “predict,” “project,” “realize,” “revolutionize,”
“seem,” “should,” “trend,” “vision,” “will,” “would” or other terms
that predict or indicate future events, trends, or expectations,
and similar expressions or the negative of such expressions may
identify forward-looking statements, but the absence of these words
or terms does not mean that a statement is not forward-looking.
Forward-looking statements in this press release include, but are
not limited to, statements regarding the following: (a) the
potential of Rockley’s sensing platform to provide real-time
insights and clinical grade data about a variety of health
conditions and monitor a variety of biomarkers from a wearable
device; (b) the potential applications for Rockley’s sensing
platform, products and technology; (c) the potential impact of the
ability to miniaturize the monitoring of key biomarkers into a
wearable device; (d) the expected demand for, and importance of,
non-invasive remote monitoring solutions outside the clinic or
hospital; (e) Rockley’s belief that its technology can create a new
class of wearable monitoring capabilities and greater peace of mind
for people who’d like meaningful insights into their health and
well-being; (f) the expectation that Rockley’s technology, along
with its cloud-enabled AI capabilities, will satisfy market demand
for non-invasive remote health monitoring solutions; and (g) the
anticipated and potential features, scope, goals, and benefits of
the Company’s platform, products, and technology.
Forward-looking statements are subject to several risks and
uncertainties (many of which are beyond Rockley’s control) or other
assumptions that may cause actual results or performance to differ
materially from those expressed or implied by these forward-looking
statements. These risks and uncertainties include, but are not
limited to, the following: (i) Rockley’s ability to achieve
customer acceptance and commercial production of its products and
technology, including in a timely and cost-effective manner; (ii)
Rockley’s ability to achieve customer design wins and convert
memoranda of understanding and development contracts into
production contracts; (iii) risks related to purchase orders,
including the lack of long-term purchase commitments, the
cancellation, reduction, delay, or other changes in customer
purchase orders, and if and to the extent customers seek to enter
into licensing arrangements in lieu of purchases; (iv) Rockley’s
history of losses and need for additional capital and its ability
to access additional financing to support its operations and
execute on its business plan, as well as the risks associated
therewith; (v) legal and regulatory risks; (vi) risks associated
with its fabless manufacturing model and dependency on third-party
suppliers; (vii) Rockley’s reliance on a few significant customers
for a majority of its revenue and its ability to expand and
diversify its customer base; (viii) Rockley’s financial
performance; (ix) the impacts of COVID-19 on Rockley, its customers
and suppliers, its target markets, and the global economy; (x)
Rockley’s ability to successfully manage growth and its operations
as a public company; (xi) fluctuations in Rockley’s stock price and
Rockley’s ability to maintain the listing of its ordinary shares on
the NYSE; (xii) Rockley’s ability to anticipate and respond to
industry trends and customer requirements; (xiii) changes in the
current and future markets in which Rockley is or may be engaged;
(xiv) risks related to competition and intellectual property; (xv)
market opportunity and demand for Rockley’s products and
technology, as well as the customer products into which Rockley’s
products and technology are incorporated; (xvi) risks related to
international operations; (xvii) risks related to cybersecurity,
privacy, and infrastructure; (xviii) risks related to financial and
accounting matters; (xix) general economic, financial, political,
and business conditions, both domestic and foreign; (xx) Rockley’s
ability to realize the anticipated benefits of its recently
completed business combination with SC Health Corporation; and
(xxi) Rockley’s ability to realize the anticipated benefits of
strategic partnerships, as well as other factors described under
the heading “Risk Factors” in Rockley’s quarterly report on Form
10-Q for the quarter ended September 30, 2021, and in other
documents Rockley files with the Securities and Exchange Commission
in the future.
The forward-looking statements contained in this press release
are based on various assumptions, whether or not identified in this
press release, and on Rockley’s current expectations, beliefs, and
assumptions and are not predictions of actual performance. If any
of these risks or uncertainties materialize, or should any of these
assumptions prove incorrect, actual results may differ materially
from those discussed in or implied by these forward-looking
statements. There can be no assurance that future developments
affecting Rockley will be those that have been anticipated. These
forward-looking statements speak only as of the date hereof and
Rockley does not intend to update or revise any forward-looking
statements, whether because of new information, future events, or
otherwise, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220127005321/en/
Media Debra Raine RaineMakers Telephone: +1 415-349-7432 Email:
rockley-pr@rainemakers.com
Investors Gwyn Lauber Rockley Photonics Telephone: +1
626-995-0001 Email: investors@rockleyphotonics.com
Rockley Photonics (NYSE:RKLY)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Rockley Photonics (NYSE:RKLY)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
